Pharmaceutical

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics”, “Monopar”, or the “Company”), a...

Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical...

Global Wearable AI Market to Surpass USD 303.59 Billion by 2035 | Growing at a CAGR 17.6 — Transforming Healthcare, Lifestyle, and Enterprise Productivity

The convergence of AI-driven health analytics, multimodal sensing, and next-gen form factors is reshaping the role of wearables in everyday life...

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

Full year fiscal 2025 net revenue of $66.4 millionFull year fiscal 2025 net loss of $13.6 millionFull year fiscal 2025...

PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials

BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- PathAI, the global leader in AI-powered pathology, today announced the integration of AIM-HI...

PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.

HHS Advances Fight Against Long COVID with Patient Roundtables and New National Efforts TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE)...

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity

error: Content is protected !!